FDA ENFORCEMENT POLICY ON UNAPPROVED IVDs "ENCOURAGES" DEVELOPMENT OF CERTIFICATION PROGRAMS FOR PROPER RESEARCH/INVESTIGATIONAL USE
This article was originally published in The Gray Sheet
Executive Summary
In vitro diagnostics vendors whose products are intended for research or investigational use only are being asked by FDA -- but not required -- to establish certification programs to prevent improper commercialization of the non-approved tests.